NHGRI welcomes new education and policy fellows
Elizabeth Tuck, M.A., and Katherine Blizinsky, Ph.D.,
will begin their fellowships - sponsored by NHGRI and the American Society of Human Genetics - in September 2014. Ms. Tuck starts her fellowship in the new Genetics and Education Fellowship program, while Dr. Blizinsky starts hers in the Genetics and Public Policy Fellowship program. Read more
Genome Advance of the Month
Researchers examine disease-causing mutations in mitochondrial genomes
The study of genetic disease
has often centered on the human nuclear genome. In contrast, the other genome that resides within us, the mitochondrial genome, has received less attention. July's Genome Advance of the Month features a study in the July 22 issue of Proceedings of the National Academy of Sciences
, which examined disease-causing mutations in the mitochondrial genomes of otherwise healthy people. Read more
NIH issues finalized policy on genomic data sharing
The National Institutes of Health has issued
a final NIH Genomic Data Sharing (GDS) policy. GDS will promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants.
Read the NIH Genomic Data Sharing Policy
Read the News Release
Video now available
Dr. Elaine Mardis on next-generation sequencing technologies
Recently, Elaine Mardis, Ph.D.
, Director of Technology Development for The Genome Institute at Washington University in St. Louis, presented Next-Generation Sequencing Technologies
, the 14th and final lecture for the 2014 Current Topics in Genome Analysis (CTGA) series. Dr. Mardis is a preeminent leader in the field of next-generation sequencing.
View the video
Read about the 2014 CTGA series
FDA proposes oversight of laboratory-developed tests
The U.S. Food and Drug Administration (FDA)
has announced steps to ensure that certain tests used by health care professionals to diagnose and treat patients provide accurate, consistent and reliable results. These steps come at a critical time for genomic, or precision, medicine. As more and more genetic tests are developed and marketed, the public must be confident in the accuracy and clinical validity of these tests. Read the FDA releaseRead a statement from NIH Director Francis Collins